indocyanine green has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 12 (63.16) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Gao, W; Hu, X; Liu, Z; Song, H; Wang, W; Zeng, L; Zhang, J; Zhang, Q; Zheng, C | 1 |
| Gai, Y; Ji, H; Jiang, D; Lan, X; Liu, Q; Long, Y; Pan, Z; Qin, C; Shao, F; Song, W; Song, X; Song, Y; Wang, K; Zhu, J; Zhu, K; Zhu, Z | 1 |
| Cai, Y; He, Y; Hu, Z; Lv, Z; Meng, X; Mou, X; Pan, Y; Zhao, X | 1 |
| Brinker, CJ; Guo, J; He, P; Huang, J; Kong, F; Lei, Q; Li, Z; Liu, K; Liu, L; Ouyang, Q; Shang, T; Shi, J; Wang, W; Xue, L; Yang, B; Zhu, W | 1 |
| Dong, Y; Fu, H; Kong, R; Wang, X; Yang, B; Yang, Z; Zheng, G | 1 |
| Bai, L; Chen, Q; Cheng, Y; Jiang, X; Li, C; Qian, Z; Shan, T; Wang, Y | 1 |
| Cai, Y; Chen, Y; Gao, X; Han, Z; Jin, J; Qian, Y; Yang, D; Yang, Z | 1 |
| Chen, M; Li, MJ; Liu, WL; Luo, XJ; Lv, RC; Ming, ZH; Song, L; Zhang, GJ; Zhang, LX; Zhang, YQ; Zhu, YY | 1 |
| Guan, X; Li, S; Li, T; Liu, Y; Qin, X; Tian, Y; Wang, Y; Wu, C; Xu, J; Yang, H; Zhang, Y | 1 |
| Jin, X; Lu, X; Lv, H; Zhang, Z | 1 |
| Jiao, J; Li, L; Lu, Y; Ma, Z; Peng, M; Xu, X; Yang, X; Yang, Z; Zhang, R | 1 |
| He, J; He, Q; Li, J; Li, M; Liu, Y; Mei, L; Qiu, Y; Ren, K; Wang, X; Yu, Q; Zhang, Z | 1 |
| da Silva, D; Goldfeder, M; Goldman, E; Hershkovitz, D; Kajal, A; Schroeder, A; Schroeder, JE; Shainsky-Roitman, J; Vardi-Oknin, D; Yaari, Z; Zinger, A | 1 |
| Dang, MN; Day, ES; Valcourt, DM | 1 |
| Howard, CB; Huang, L; Li, B; Mahler, SM; Tang, J; Thurecht, KJ; Wu, Y; Xu, ZP | 1 |
| Fernandez, B; Hardy, CW; Shemesh, CS; Yu, DS; Zhang, H | 1 |
| Moshkelani, D; Shemesh, CS; Zhang, H | 1 |
| Ding, Y; Ji, T; Li, Y; Nie, G; Su, S; Tian, Y; Wu, M; Wu, Y | 1 |
| Kannadorai, RK; Sidney, YW; Udumala, SK | 1 |
19 other study(ies) available for indocyanine green and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Drug self-delivery nanorods enhance photodynamic therapy of triple-negative breast cancer by inhibiting oxidative phosphorylation.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Electron Transport Complex III; Glutathione; Humans; Indocyanine Green; Mice; Nanotubes; Oxidative Phosphorylation; Photochemotherapy; Photosensitizing Agents; Triple Negative Breast Neoplasms | 2022 |
Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer.
Topics: Antibodies, Monoclonal; Cell Line, Tumor; Humans; Hydrazines; Immunoconjugates; Indocyanine Green; Nectins; Nicotinic Acids; Photothermal Therapy; Single Photon Emission Computed Tomography Computed Tomography; Tissue Distribution; Triple Negative Breast Neoplasms | 2022 |
Engineered Red Blood Cell Membrane-Coating Salidroside/Indocyanine Green Nanovesicles for High-Efficiency Hypoxic Targeting Phototherapy of Triple-Negative Breast Cancer.
Topics: Cell Line, Tumor; Erythrocyte Membrane; Glucosides; Humans; Hypoxia; Indocyanine Green; Nanoparticles; Phenols; Photochemotherapy; Phototherapy; Triple Negative Breast Neoplasms | 2022 |
Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy.
Topics: Albumins; Animals; Cell Line, Tumor; Humans; Hyperthermia, Induced; Indocyanine Green; Ligands; Mice; Mice, Inbred BALB C; Nanoparticles; Phototherapy; Photothermal Therapy; Serum Albumin, Human; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2022 |
Boosting immunotherapy of triple negative breast cancer through the synergy of mild PTT and Fe-loaded organosilica nanoparticles.
Topics: CD8-Positive T-Lymphocytes; Humans; Hyaluronic Acid; Immunotherapy; Indocyanine Green; Nanoparticles; Triple Negative Breast Neoplasms | 2022 |
Versatile Red Blood Cells for Triple-Negative Breast Cancer Treatment via Stepwise Photoactivations.
Topics: Cell Line, Tumor; Erythrocytes; Humans; Hyperthermia, Induced; Indocyanine Green; Nanoparticles; Photosensitizing Agents; Phototherapy; Triple Negative Breast Neoplasms | 2023 |
Hypoxia-responsive covalent organic framework by single NIR laser-triggered for multimodal synergistic therapy of triple-negative breast cancer.
Topics: Cell Line, Tumor; Humans; Hypoxia; Indocyanine Green; Infrared Rays; Metal-Organic Frameworks; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2023 |
Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer.
Topics: Animals; B7-H1 Antigen; Gadolinium DTPA; Humans; Immunotherapy; Indocyanine Green; Magnetic Resonance Imaging; Mice; Triple Negative Breast Neoplasms | 2023 |
Acid-Triggered Charge-Convertible Graphene-Based All-in-One Nanocomplex for Enhanced Genetic Phototherapy of Triple-Negative Breast Cancer.
Topics: Animals; Antagomirs; Cell Line, Tumor; Cell Survival; Female; Graphite; Humans; Hydrogen-Ion Concentration; Indocyanine Green; Lasers; Lysosomes; Mice, Nude; MicroRNAs; Nanoparticles; Photosensitizing Agents; Phototherapy; Polymers; Reactive Oxygen Species; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Delivery Systems; Endocytosis; Female; Humans; Hydrodynamics; Indocyanine Green; Liposomes; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Photosensitizing Agents; Reactive Oxygen Species; Sesquiterpenes; Temperature; Tissue Distribution; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden | 2020 |
A Honeycomb-Like Bismuth/Manganese Oxide Nanoparticle with Mutual Reinforcement of Internal and External Response for Triple-Negative Breast Cancer Targeted Therapy.
Topics: Bismuth; Cell Line, Tumor; Humans; Indocyanine Green; Manganese; Manganese Compounds; Nanoparticles; Oxides; Photochemotherapy; Triple Negative Breast Neoplasms | 2021 |
Macrophage-mediated multi-mode drug release system for photothermal combined with anti-inflammatory therapy against postoperative recurrence of triple negative breast cancer.
Topics: Anti-Inflammatory Agents; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Humans; Hyperthermia, Induced; Indocyanine Green; Macrophages; Neoplasm Recurrence, Local; Triple Negative Breast Neoplasms | 2021 |
Nanoparticles target early-stage breast cancer metastasis in vivo.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Europium; Female; Humans; Indocyanine Green; Liposomes; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Neoplasm Transplantation; Optical Imaging; Rhodamines; Tissue Distribution; Triple Negative Breast Neoplasms | 2017 |
IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endocytosis; Female; Fluorescence; Humans; Hyperthermia, Induced; Indocyanine Green; Light; Mice, Nude; Nanoparticles; Phototherapy; Polylactic Acid-Polyglycolic Acid Copolymer; Time Factors; Triple Negative Breast Neoplasms | 2019 |
Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy.
Topics: Animals; Calcium Phosphates; Cell Line, Tumor; Coloring Agents; Drug Carriers; Drug Delivery Systems; Female; Genetic Therapy; Humans; Hyperthermia, Induced; Indocyanine Green; Lipids; Mice; Mice, Inbred BALB C; Nanoparticles; RNAi Therapeutics; Triple Negative Breast Neoplasms | 2019 |
Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Diffusion; Humans; Indocyanine Green; Liposomes; Nanocapsules; Photochemotherapy; Radiation-Sensitizing Agents; Treatment Outcome; Triple Negative Breast Neoplasms | 2014 |
Thermosensitive liposome formulated indocyanine green for near-infrared triggered photodynamic therapy: in vivo evaluation for triple-negative breast cancer.
Topics: Animals; Breast; Cell Line, Tumor; Delayed-Action Preparations; Female; Fluorescent Dyes; Humans; Indocyanine Green; Liposomes; Mice, Nude; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Temperature; Triple Negative Breast Neoplasms | 2015 |
"Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Endocytosis; Female; Humans; Indocyanine Green; Inhibitor of Apoptosis Proteins; Intracellular Space; Lactic Acid; Methacrylates; Mice; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; Survivin; Triple Negative Breast Neoplasms | 2015 |
Noninvasive in vivo multispectral optoacoustic imaging of apoptosis in triple negative breast cancer using indocyanine green conjugated phosphatidylserine monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Female; Indocyanine Green; Mice; Mice, Nude; Optical Imaging; Phosphatidylserines; Photoacoustic Techniques; Triple Negative Breast Neoplasms | 2016 |